Funato T
Department of Clinical & Laboratory Medicine, Tohoku University, School of Medicine.
Nihon Rinsho. 1998 Mar;56(3):701-4.
Gene transfer vectors based on the replication-defective adeno-associated virus (AAV) are emerging as promising vehicles for gene therapeutic approaches for the neurologic disease, cystic fibrosis and cancers. AAV vectors have been used to efficiently transduce genes into cells in vitro and in vivo. However, transduced recombinant AAV vectors are integrated into human chromosomes. Thus we have discussed that the review about the AAV vectors and transduction, and reported the results used AAV vectors for expression of ribozyme.
基于复制缺陷型腺相关病毒(AAV)的基因转移载体正成为用于神经疾病、囊性纤维化和癌症基因治疗方法的有前景的载体。AAV载体已被用于在体外和体内将基因高效转导到细胞中。然而,转导的重组AAV载体整合到人类染色体中。因此,我们讨论了关于AAV载体和转导的综述,并报告了使用AAV载体表达核酶的结果。